Astrix, the market leader in strategic, technical and staffing services for life science organisations, announced today the appointment of Sandy Tremps to its board of directors. Sandy is a successful industry veteran bringing over 30 years of life sciences IT leadership to Astrix.

“Digital transformation remains a top priority for the life sciences industry and that’s not changing anytime soon,” said Dale Curtis, CEO of Astrix. “There’s no better way to drive value for clients than having a successful executive helping guide strategic direction at Astrix. We’re excited to have a wildly successful industry veteran like Sandy on board and look forward to her insights & contributions.”

Sandy’s experience spans many aspects of IT, including delivery, strategic planning, portfolio management, compliance, and process management. She joined Merck & Co in 1988 and led IT organisations across multiple divisions and spanning critical programmes in support of Merck Research Laboratories (MRL) Global Development, MRL Pre-Clinical, Global Human Health (GHH) Emerging Markets, Merck Manufacturing Division (MMD) IT Automation and MMD Project 2000. She served as divisional CIO for Merck Research Laboratories from 2016-2021.

“Astrix has created a unique one-stop-shop where they deliver the people, processes, and a technology agnostic approach to solve the most complex challenges for life sciences companies,” said Sandy Tremps. “I’m excited to share my expertise and insights to help fine-tune Astrix’s strategy so that we can continue to deliver the highest level of value for clients.”

Sandy’s appointment to the Astrix Board of Directors is effective as of 1 May 2022.